AIM IMMUNOTECH INC. Total Liabilities
AIM IMMUNOTECH INC. (AIM) had Total Liabilities of $4.99 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-07
- 2026-06-30: Liabilities $4.99M.
- 2026-03-31: Liabilities $6.46M.
- 2025-12-31: Liabilities $15.56M.
- 2025-09-30: Liabilities $11.57M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $4.99M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $6.46M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $15.56M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $11.57M 10-Q · filed 2025-11-17 |
| 2025-06-30 | $10.68M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $10.11M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $9.93M 10-K · filed 2026-03-27 |
| 2024-09-30 | $10.68M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $9.61M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $11.36M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $9.15M 10-K · filed 2025-03-27 |
| 2022-12-31 | $2.02M 10-K · filed 2024-04-01 |
| 2014-12-31 | $4.44M 10-K · filed 2015-03-19 |
| 2014-09-30 | $4.27M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $4.18M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $3.02M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $2.57M 10-K · filed 2015-03-19 |
| 2013-09-30 | $10.73M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $10.00M 10-Q · filed 2013-08-09 |
| 2013-03-31 | $10.28M 10-Q · filed 2013-05-08 |
| 2012-12-31 | $13.00M 10-K · filed 2014-03-14 |
| 2012-09-30 | $11.97M 10-Q · filed 2012-11-02 |
| 2012-06-30 | $7.58M 10-Q · filed 2012-08-08 |
| 2012-03-31 | $6.60M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $5.55M 10-K · filed 2013-03-18 |
| 2011-09-30 | $4.96M 10-Q · filed 2011-11-09 |
| 2011-06-30 | $3.93M 10-Q · filed 2011-08-05 |
| 2010-12-31 | $5.73M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |